PKP2_HUMAN - dbPTM
PKP2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PKP2_HUMAN
UniProt AC Q99959
Protein Name Plakophilin-2
Gene Name PKP2
Organism Homo sapiens (Human).
Sequence Length 881
Subcellular Localization Nucleus . Cell junction, desmosome . Nuclear and associated with desmosomes.
Protein Description May play a role in junctional plaques..
Protein Sequence MAAPGAPAEYGYIRTVLGQQILGQLDSSSLALPSEAKLKLAGSSGRGGQTVKSLRIQEQVQQTLARKGRSSVGNGNLHRTSSVPEYVYNLHLVENDFVGGRSPVPKTYDMLKAGTTATYEGRWGRGTAQYSSQKSVEERSLRHPLRRLEISPDSSPERAHYTHSDYQYSQRSQAGHTLHHQESRRAALLVPPRYARSEIVGVSRAGTTSRQRHFDTYHRQYQHGSVSDTVFDSIPANPALLTYPRPGTSRSMGNLLEKENYLTAGLTVGQVRPLVPLQPVTQNRASRSSWHQSSFHSTRTLREAGPSVAVDSSGRRAHLTVGQAAAGGSGNLLTERSTFTDSQLGNADMEMTLERAVSMLEADHMLPSRISAAATFIQHECFQKSEARKRVNQLRGILKLLQLLKVQNEDVQRAVCGALRNLVFEDNDNKLEVAELNGVPRLLQVLKQTRDLETKKQITDHTVNLRSRNGWPGAVAHACNPSTLGGQGGRITRSGVRDQPDQHGLLWNLSSNDKLKNLMITEALLTLTENIIIPFSGWPEGDYPKANGLLDFDIFYNVTGCLRNMSSAGADGRKAMRRCDGLIDSLVHYVRGTIADYQPDDKATENCVCILHNLSYQLEAELPEKYSQNIYIQNRNIQTDNNKSIGCFGSRSRKVKEQYQDVPMPEEKSNPKGVEWLWHSIVIRMYLSLIAKSVRNYTQEASLGALQNLTAGSGPMPTSVAQTVVQKESGLQHTRKMLHVGDPSVKKTAISLLRNLSRNLSLQNEIAKETLPDLVSIIPDTVPSTDLLIETTASACYTLNNIIQNSYQNARDLLNTGGIQKIMAISAGDAYASNKASKAASVLLYSLWAHTELHHAYKKAQFKKTDFVNSRTAKAYHSLKD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
10PhosphorylationAPGAPAEYGYIRTVL
CCCCCCHHCHHHHHH
19.8225394399
12PhosphorylationGAPAEYGYIRTVLGQ
CCCCHHCHHHHHHHH
6.0725106551
27PhosphorylationQILGQLDSSSLALPS
HHHCCCCCCCCCCCC
30.3428348404
28PhosphorylationILGQLDSSSLALPSE
HHCCCCCCCCCCCCC
29.1028348404
29PhosphorylationLGQLDSSSLALPSEA
HCCCCCCCCCCCCCC
22.9324719451
37UbiquitinationLALPSEAKLKLAGSS
CCCCCCCCEEECCCC
41.9421906983
37UbiquitinationLALPSEAKLKLAGSS
CCCCCCCCEEECCCC
41.9421906983
37 (in isoform 1)Ubiquitination-41.9421906983
37 (in isoform 2)Ubiquitination-41.9421906983
39MethylationLPSEAKLKLAGSSGR
CCCCCCEEECCCCCC
35.2724639879
39UbiquitinationLPSEAKLKLAGSSGR
CCCCCCEEECCCCCC
35.2722817900
43PhosphorylationAKLKLAGSSGRGGQT
CCEEECCCCCCCCCC
24.8220068231
44PhosphorylationKLKLAGSSGRGGQTV
CEEECCCCCCCCCCC
31.4320068231
46MethylationKLAGSSGRGGQTVKS
EECCCCCCCCCCCHH
48.2824129315
50PhosphorylationSSGRGGQTVKSLRIQ
CCCCCCCCCHHHHHH
32.9329514088
52MethylationGRGGQTVKSLRIQEQ
CCCCCCCHHHHHHHH
47.3521675381
52UbiquitinationGRGGQTVKSLRIQEQ
CCCCCCCHHHHHHHH
47.3529967540
53PhosphorylationRGGQTVKSLRIQEQV
CCCCCCHHHHHHHHH
20.6725056879
63PhosphorylationIQEQVQQTLARKGRS
HHHHHHHHHHHCCCC
12.8030576142
70PhosphorylationTLARKGRSSVGNGNL
HHHHCCCCCCCCCCC
37.7426657352
71PhosphorylationLARKGRSSVGNGNLH
HHHCCCCCCCCCCCC
32.4625159151
80PhosphorylationGNGNLHRTSSVPEYV
CCCCCCCCCCCCHHH
18.0123927012
81PhosphorylationNGNLHRTSSVPEYVY
CCCCCCCCCCCHHHE
29.3323927012
82PhosphorylationGNLHRTSSVPEYVYN
CCCCCCCCCCHHHEE
40.8728355574
86PhosphorylationRTSSVPEYVYNLHLV
CCCCCCHHHEEEEEE
11.3623927012
88PhosphorylationSSVPEYVYNLHLVEN
CCCCHHHEEEEEEEC
15.8823927012
102PhosphorylationNDFVGGRSPVPKTYD
CCCCCCCCCCCCHHH
33.2625159151
106UbiquitinationGGRSPVPKTYDMLKA
CCCCCCCCHHHHHHC
61.0123503661
107PhosphorylationGRSPVPKTYDMLKAG
CCCCCCCHHHHHHCC
20.7723663014
108PhosphorylationRSPVPKTYDMLKAGT
CCCCCCHHHHHHCCC
12.8923663014
112UbiquitinationPKTYDMLKAGTTATY
CCHHHHHHCCCEEEE
37.8321906983
112MethylationPKTYDMLKAGTTATY
CCHHHHHHCCCEEEE
37.8321688109
112UbiquitinationPKTYDMLKAGTTATY
CCHHHHHHCCCEEEE
37.8321906983
112 (in isoform 1)Ubiquitination-37.8321906983
112 (in isoform 2)Ubiquitination-37.8321906983
115PhosphorylationYDMLKAGTTATYEGR
HHHHHCCCEEEECCC
20.3723663014
116PhosphorylationDMLKAGTTATYEGRW
HHHHCCCEEEECCCC
18.9823663014
118PhosphorylationLKAGTTATYEGRWGR
HHCCCEEEECCCCCC
21.7321945579
119PhosphorylationKAGTTATYEGRWGRG
HCCCEEEECCCCCCC
17.5821945579
125MethylationTYEGRWGRGTAQYSS
EECCCCCCCCCCCCC
32.1230760701
127PhosphorylationEGRWGRGTAQYSSQK
CCCCCCCCCCCCCCC
14.8223927012
130PhosphorylationWGRGTAQYSSQKSVE
CCCCCCCCCCCCCHH
14.0721945579
131PhosphorylationGRGTAQYSSQKSVEE
CCCCCCCCCCCCHHH
17.7621945579
132PhosphorylationRGTAQYSSQKSVEER
CCCCCCCCCCCHHHH
36.3721945579
134UbiquitinationTAQYSSQKSVEERSL
CCCCCCCCCHHHHHH
59.4221906983
134UbiquitinationTAQYSSQKSVEERSL
CCCCCCCCCHHHHHH
59.4222817900
134 (in isoform 1)Ubiquitination-59.4221906983
134 (in isoform 2)Ubiquitination-59.4221906983
135PhosphorylationAQYSSQKSVEERSLR
CCCCCCCCHHHHHHH
27.4223927012
140PhosphorylationQKSVEERSLRHPLRR
CCCHHHHHHHCCHHH
32.7924719451
151PhosphorylationPLRRLEISPDSSPER
CHHHCCCCCCCCCCH
17.1819664994
154PhosphorylationRLEISPDSSPERAHY
HCCCCCCCCCCHHHC
51.6923927012
155PhosphorylationLEISPDSSPERAHYT
CCCCCCCCCCHHHCC
37.8523927012
161PhosphorylationSSPERAHYTHSDYQY
CCCCHHHCCCCCCCC
12.7421945579
162PhosphorylationSPERAHYTHSDYQYS
CCCHHHCCCCCCCCC
12.6821945579
164PhosphorylationERAHYTHSDYQYSQR
CHHHCCCCCCCCCCH
30.1621945579
166PhosphorylationAHYTHSDYQYSQRSQ
HHCCCCCCCCCCHHC
16.6221945579
168PhosphorylationYTHSDYQYSQRSQAG
CCCCCCCCCCHHCCC
10.6721945579
169PhosphorylationTHSDYQYSQRSQAGH
CCCCCCCCCHHCCCC
12.0021945579
172PhosphorylationDYQYSQRSQAGHTLH
CCCCCCHHCCCCCCC
19.4228355574
177PhosphorylationQRSQAGHTLHHQESR
CHHCCCCCCCCHHHH
27.2023663014
183PhosphorylationHTLHHQESRRAALLV
CCCCCHHHHCHHEEC
22.0928355574
194PhosphorylationALLVPPRYARSEIVG
HEECCCCHHHCCEEE
16.4923927012
197PhosphorylationVPPRYARSEIVGVSR
CCCCHHHCCEEEEEC
24.4128355574
203PhosphorylationRSEIVGVSRAGTTSR
HCCEEEEECCCCCCC
15.5228355574
204MethylationSEIVGVSRAGTTSRQ
CCEEEEECCCCCCCH
34.33115487731
207PhosphorylationVGVSRAGTTSRQRHF
EEEECCCCCCCHHCC
22.1823911959
208PhosphorylationGVSRAGTTSRQRHFD
EEECCCCCCCHHCCH
22.46-
216PhosphorylationSRQRHFDTYHRQYQH
CCHHCCHHCCHHHHC
21.9328152594
217PhosphorylationRQRHFDTYHRQYQHG
CHHCCHHCCHHHHCC
9.2420007894
221PhosphorylationFDTYHRQYQHGSVSD
CHHCCHHHHCCCCCC
11.4823090842
225PhosphorylationHRQYQHGSVSDTVFD
CHHHHCCCCCCCCCC
19.1426657352
227PhosphorylationQYQHGSVSDTVFDSI
HHHCCCCCCCCCCCC
29.3028857561
229PhosphorylationQHGSVSDTVFDSIPA
HCCCCCCCCCCCCCC
18.6326657352
233PhosphorylationVSDTVFDSIPANPAL
CCCCCCCCCCCCCHH
21.0023090842
242PhosphorylationPANPALLTYPRPGTS
CCCCHHCCCCCCCCC
32.1223090842
243PhosphorylationANPALLTYPRPGTSR
CCCHHCCCCCCCCCC
9.3826657352
248PhosphorylationLTYPRPGTSRSMGNL
CCCCCCCCCCCHHHH
24.5328857561
249PhosphorylationTYPRPGTSRSMGNLL
CCCCCCCCCCHHHHH
28.4228857561
251PhosphorylationPRPGTSRSMGNLLEK
CCCCCCCCHHHHHHH
30.7019664994
258UbiquitinationSMGNLLEKENYLTAG
CHHHHHHHCCEECCC
51.7521906983
258UbiquitinationSMGNLLEKENYLTAG
CHHHHHHHCCEECCC
51.7522817900
258 (in isoform 1)Ubiquitination-51.7521906983
258 (in isoform 2)Ubiquitination-51.7521906983
261PhosphorylationNLLEKENYLTAGLTV
HHHHHCCEECCCCEE
13.4021082442
263PhosphorylationLEKENYLTAGLTVGQ
HHHCCEECCCCEECC
14.3326356563
267PhosphorylationNYLTAGLTVGQVRPL
CEECCCCEECCEECC
22.98-
281PhosphorylationLVPLQPVTQNRASRS
CCCCCCCCCCCCCCC
27.1524719451
286PhosphorylationPVTQNRASRSSWHQS
CCCCCCCCCCCCCHH
29.4728152594
288PhosphorylationTQNRASRSSWHQSSF
CCCCCCCCCCCHHHH
34.9723927012
289PhosphorylationQNRASRSSWHQSSFH
CCCCCCCCCCHHHHH
27.7128355574
293PhosphorylationSRSSWHQSSFHSTRT
CCCCCCHHHHHCCCH
23.2923927012
294PhosphorylationRSSWHQSSFHSTRTL
CCCCCHHHHHCCCHH
22.0228355574
297PhosphorylationWHQSSFHSTRTLREA
CCHHHHHCCCHHHHH
19.9928355574
298PhosphorylationHQSSFHSTRTLREAG
CHHHHHCCCHHHHHC
21.0730206219
300PhosphorylationSSFHSTRTLREAGPS
HHHHCCCHHHHHCCC
30.2023927012
302MethylationFHSTRTLREAGPSVA
HHCCCHHHHHCCCEE
30.9881452661
307PhosphorylationTLREAGPSVAVDSSG
HHHHHCCCEEECCCC
23.0728857561
312PhosphorylationGPSVAVDSSGRRAHL
CCCEEECCCCCEEEE
28.2630266825
313PhosphorylationPSVAVDSSGRRAHLT
CCEEECCCCCEEEEE
31.6830266825
320PhosphorylationSGRRAHLTVGQAAAG
CCCEEEEEEECCCCC
16.8423403867
329PhosphorylationGQAAAGGSGNLLTER
ECCCCCCCCCCCCCC
24.4820031617
334PhosphorylationGGSGNLLTERSTFTD
CCCCCCCCCCCCCCH
32.3030266825
337PhosphorylationGNLLTERSTFTDSQL
CCCCCCCCCCCHHHC
22.9520860994
340PhosphorylationLTERSTFTDSQLGNA
CCCCCCCCHHHCCCC
34.5327794612
342PhosphorylationERSTFTDSQLGNADM
CCCCCCHHHCCCCCH
25.0126657352
352PhosphorylationGNADMEMTLERAVSM
CCCCHHHHHHHHHHH
16.5027794612
358PhosphorylationMTLERAVSMLEADHM
HHHHHHHHHHHHHHC
19.3728857561
390DimethylationQKSEARKRVNQLRGI
CHHHHHHHHHHHHHH
27.37-
390MethylationQKSEARKRVNQLRGI
CHHHHHHHHHHHHHH
27.37115372705
395DimethylationRKRVNQLRGILKLLQ
HHHHHHHHHHHHHHH
21.97-
395MethylationRKRVNQLRGILKLLQ
HHHHHHHHHHHHHHH
21.97115372711
405UbiquitinationLKLLQLLKVQNEDVQ
HHHHHHHHCCCHHHH
50.8221906983
405UbiquitinationLKLLQLLKVQNEDVQ
HHHHHHHHCCCHHHH
50.8221906983
405UbiquitinationLKLLQLLKVQNEDVQ
HHHHHHHHCCCHHHH
50.8222817900
405 (in isoform 1)Ubiquitination-50.8221906983
405 (in isoform 2)Ubiquitination-50.8221906983
430UbiquitinationVFEDNDNKLEVAELN
HEECCCCCEEHHHHC
49.2229967540
447UbiquitinationPRLLQVLKQTRDLET
HHHHHHHHHCCCCCH
51.2529967540
459PhosphorylationLETKKQITDHTVNLR
CCHHHHCCCCCCCCH
21.16-
462PhosphorylationKKQITDHTVNLRSRN
HHHCCCCCCCCHHCC
17.56-
466 (in isoform 2)Phosphorylation-28.5022210691
467 (in isoform 2)Phosphorylation-33.0122210691
470UbiquitinationVNLRSRNGWPGAVAH
CCCHHCCCCCCCHHH
30.7423000965
470 (in isoform 2)Ubiquitination-30.74-
472UbiquitinationLRSRNGWPGAVAHAC
CHHCCCCCCCHHHCC
23.4323000965
514UbiquitinationWNLSSNDKLKNLMIT
EECCCCHHHHHHHHH
66.6623000965
516UbiquitinationLSSNDKLKNLMITEA
CCCCHHHHHHHHHHH
54.5023000965
597PhosphorylationVRGTIADYQPDDKAT
HHHCCCCCCCCCHHH
16.96-
599UbiquitinationGTIADYQPDDKATEN
HCCCCCCCCCHHHCC
45.6023000965
603S-palmitoylationDYQPDDKATENCVCI
CCCCCCHHHCCEEEE
27.4325002405
612UbiquitinationENCVCILHNLSYQLE
CCEEEEEECHHHEEE
17.1729967540
616PhosphorylationCILHNLSYQLEAELP
EEEECHHHEEEECCC
21.93-
626PhosphorylationEAELPEKYSQNIYIQ
EECCCHHHCCCEEEE
17.5221945579
627PhosphorylationAELPEKYSQNIYIQN
ECCCHHHCCCEEEEC
28.0221945579
631PhosphorylationEKYSQNIYIQNRNIQ
HHHCCCEEEECCCEE
12.1921945579
643UbiquitinationNIQTDNNKSIGCFGS
CEECCCCCCCCCCCC
50.1023000965
650PhosphorylationKSIGCFGSRSRKVKE
CCCCCCCCCCHHHHH
13.5624719451
656UbiquitinationGSRSRKVKEQYQDVP
CCCCHHHHHHHCCCC
41.9829967540
659PhosphorylationSRKVKEQYQDVPMPE
CHHHHHHHCCCCCCC
14.0521945579
686PhosphorylationHSIVIRMYLSLIAKS
HHHHHHHHHHHHHHH
5.3620068231
688PhosphorylationIVIRMYLSLIAKSVR
HHHHHHHHHHHHHHH
10.5522985185
692UbiquitinationMYLSLIAKSVRNYTQ
HHHHHHHHHHHHHCH
42.3529967540
693PhosphorylationYLSLIAKSVRNYTQE
HHHHHHHHHHHHCHH
19.7920068231
702UbiquitinationRNYTQEASLGALQNL
HHHCHHHHHHHHHHC
26.9529901268
703UbiquitinationNYTQEASLGALQNLT
HHCHHHHHHHHHHCC
6.3229967540
736UbiquitinationSGLQHTRKMLHVGDP
HCCHHHHHEECCCCH
47.1429967540
744PhosphorylationMLHVGDPSVKKTAIS
EECCCCHHHHHHHHH
51.84-
746UbiquitinationHVGDPSVKKTAISLL
CCCCHHHHHHHHHHH
49.0629901268
747UbiquitinationVGDPSVKKTAISLLR
CCCHHHHHHHHHHHH
40.8229967540
748PhosphorylationGDPSVKKTAISLLRN
CCHHHHHHHHHHHHH
24.4129083192
751PhosphorylationSVKKTAISLLRNLSR
HHHHHHHHHHHHHHH
20.9129083192
761PhosphorylationRNLSRNLSLQNEIAK
HHHHHCHHHHHHHHH
31.3028355574
816PhosphorylationNARDLLNTGGIQKIM
HHHHHHHCCHHHHEE
36.4323532336
830UbiquitinationMAISAGDAYASNKAS
EEEECCHHHHCCHHH
10.8129967540
831PhosphorylationAISAGDAYASNKASK
EEECCHHHHCCHHHH
18.4628985074
833PhosphorylationSAGDAYASNKASKAA
ECCHHHHCCHHHHHH
26.6227307780
845PhosphorylationKAASVLLYSLWAHTE
HHHHHHHHHHHHHHH
9.5028985074
846PhosphorylationAASVLLYSLWAHTEL
HHHHHHHHHHHHHHH
19.8728985074
864UbiquitinationYKKAQFKKTDFVNSR
HHHHHHCCCCCCCHH
55.40-
870PhosphorylationKKTDFVNSRTAKAYH
CCCCCCCHHHHHHHH
26.2127470641
874UbiquitinationFVNSRTAKAYHSLKD
CCCHHHHHHHHHCCC
49.1929967540
876PhosphorylationNSRTAKAYHSLKD--
CHHHHHHHHHCCC--
7.4030266825
878PhosphorylationRTAKAYHSLKD----
HHHHHHHHCCC----
25.1630266825

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
82SPhosphorylationKinaseTAK1O43318
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PKP2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PKP2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
DESP_HUMANDSPphysical
11790773
PLAK_HUMANJUPphysical
11790773
DSG1_HUMANDSG1physical
11790773
DSG2_HUMANDSG2physical
11790773
DSC1_HUMANDSC1physical
11790773
DSC2_HUMANDSC2physical
11790773
RPC1_HUMANPOLR3Aphysical
11416169
K1C18_HUMANKRT18physical
10852826
K2C5_HUMANKRT5physical
10852826
MARK3_HUMANMARK3physical
12941695
MTUS2_HUMANMTUS2physical
25416956
NDEL1_HUMANNDEL1physical
25416956

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
609040Arrhythmogenic right ventricular dysplasia, familial, 9 (ARVD9)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PKP2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151 AND SER-154, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151 AND SER-155, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151; SER-154; SER-155;SER-197 AND SER-329, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151; SER-154 ANDSER-155, AND MASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132 AND SER-169, ANDMASS SPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-12; TYR-86; TYR-161;TYR-166; TYR-168 AND TYR-217, AND MASS SPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-168, AND MASSSPECTROMETRY.

TOP